Scholar Rock Holding Co. (NASDAQ:SRRK) Expected to Announce Earnings of -$0.68 Per Share

Wall Street analysts expect Scholar Rock Holding Co. (NASDAQ:SRRKGet Rating) to announce ($0.68) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Scholar Rock’s earnings, with the lowest EPS estimate coming in at ($1.16) and the highest estimate coming in at ($0.16). Scholar Rock posted earnings per share of ($0.76) during the same quarter last year, which indicates a positive year over year growth rate of 10.5%. The firm is expected to issue its next earnings results on Monday, January 1st.

On average, analysts expect that Scholar Rock will report full year earnings of ($3.96) per share for the current year, with EPS estimates ranging from ($4.37) to ($3.18). For the next financial year, analysts anticipate that the company will post earnings of ($4.30) per share, with EPS estimates ranging from ($5.99) to ($3.20). Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that cover Scholar Rock.

Scholar Rock (NASDAQ:SRRKGet Rating) last issued its quarterly earnings data on Monday, March 7th. The company reported ($0.97) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($1.05) by $0.08. The business had revenue of $4.05 million for the quarter, compared to the consensus estimate of $4.33 million. Scholar Rock had a negative net margin of 700.46% and a negative return on equity of 64.57%. During the same period in the previous year, the firm earned ($2.81) EPS.

A number of research analysts have issued reports on SRRK shares. Jefferies Financial Group downgraded shares of Scholar Rock from a “buy” rating to a “hold” rating and reduced their price objective for the company from $52.00 to $28.00 in a research report on Wednesday, December 22nd. Zacks Investment Research upgraded shares of Scholar Rock from a “sell” rating to a “hold” rating in a report on Friday, March 11th. Wedbush restated an “outperform” rating and set a $50.00 target price on shares of Scholar Rock in a report on Monday, March 7th. Finally, HC Wainwright initiated coverage on shares of Scholar Rock in a report on Wednesday, March 23rd. They set a “buy” rating and a $24.00 target price on the stock. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $39.50.

Scholar Rock stock traded up $0.22 during mid-day trading on Monday, reaching $10.12. 30,655 shares of the company traded hands, compared to its average volume of 288,856. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.13 and a quick ratio of 4.13. The stock’s 50 day moving average price is $14.67. The stock has a market capitalization of $357.21 million, a price-to-earnings ratio of -2.79 and a beta of 0.24. Scholar Rock has a 52-week low of $9.50 and a 52-week high of $44.95.

A number of institutional investors have recently made changes to their positions in the stock. BlackRock Inc. boosted its stake in Scholar Rock by 4.1% in the 4th quarter. BlackRock Inc. now owns 2,288,026 shares of the company’s stock worth $56,835,000 after purchasing an additional 89,921 shares in the last quarter. Wellington Management Group LLP boosted its stake in Scholar Rock by 124.9% in the 3rd quarter. Wellington Management Group LLP now owns 1,276,488 shares of the company’s stock worth $42,150,000 after purchasing an additional 708,831 shares in the last quarter. Victory Capital Management Inc. boosted its stake in Scholar Rock by 25.9% in the 4th quarter. Victory Capital Management Inc. now owns 1,273,193 shares of the company’s stock worth $31,626,000 after purchasing an additional 262,130 shares in the last quarter. State Street Corp boosted its stake in Scholar Rock by 4.1% in the 4th quarter. State Street Corp now owns 1,246,877 shares of the company’s stock worth $30,972,000 after purchasing an additional 49,411 shares in the last quarter. Finally, Norges Bank bought a new position in Scholar Rock in the 4th quarter worth about $14,267,000. Institutional investors own 82.42% of the company’s stock.

About Scholar Rock (Get Rating)

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.

See Also

Get a free copy of the Zacks research report on Scholar Rock (SRRK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Scholar Rock (NASDAQ:SRRK)

Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with MarketBeat.com's FREE daily email newsletter.